amr industry alliance
We drive and measure the life-sciences industry progress to curb antimicrobial resistance in four different areas:
Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection, and improve appropriate use of antibiotics.
amr in numbers
Life-sciences at the forefront of the battle against AMR
Development of National Action Plans
from the blog
Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri...Read more view all